AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...

The following is a summary of "Radiation decreases bronchial epithelial progenitor function as assessed by organoid formation ...